| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3353183 | Immunity | 2012 | 4 Pages |
Abstract
In this issue of Immunity, Yu et al. (2012) outline a fascinating model in which TLR7-mediated antibody production acts as a dominant immunosurveillance mechanism against endogenous retroviruses (ERVs), with additional support of TLR3 and TLR9 that function to prevent ERV-mediated malignancy.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Arun K. Mankan, Veit Hornung,